Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2214)	4/1/2008 12:39:04 PM
From: Jibacoa	Respond to of 3722

NSTK Is up 12.34% on volume of 121,580 about 1/3 its ADV. bigcharts.marketwatch.com The stock needs to close above its Feb25 H at the $3 level before it can test the Dec7 H at $4.50 (The close of its Nov7 DG above the $10.25 level is a different subject.<g>) bigcharts.marketwatch.com In Nov was when it announced that P&G Pharmaceuticals terminated an agreement for NSTK's Teriparatide nasal spray to treat osteoporosis & NSTK said that it was going to continue with the research on the drug. The stock trades around 1.6xBV with a negative CF around $1.80 The short ratio is close to 8x its ADV The all time H in March 2006 was $23.14 bigcharts.marketwatch.com Bernard